Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
Reactive oxygen species (ROS)-sensitive drug delivery systems (DDS) specifically responding to altered levels of ROS in the pathological microenvironment have emerged as an effective means to enhance the pharmaceutical efficacy of conventional nanomedicines, while simultaneously reducing side effect...
Main Authors: | Arianna Rinaldi, Riccardo Caraffi, Maria Vittoria Grazioli, Natalia Oddone, Luciana Giardino, Giovanni Tosi, Maria Angela Vandelli, Laura Calzà, Barbara Ruozi, Jason Thomas Duskey |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Polymers |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4360/14/4/687 |
Similar Items
-
Reprogramming Macrophage Polarization, Depleting ROS by Astaxanthin and Thioketal‐Containing Polymers Delivering Rapamycin for Osteoarthritis Treatment
by: Huiyun Li, et al.
Published: (2024-03-01) -
Microfluidic Technology for the Production of Hybrid Nanomedicines
by: Ilaria Ottonelli, et al.
Published: (2021-09-01) -
Tunneling Nanotubes: A New Target for Nanomedicine?
by: Ilaria Ottonelli, et al.
Published: (2022-02-01) -
Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment
by: Natalia Oddone, et al.
Published: (2020-05-01) -
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
by: Jason Thomas Duskey, et al.
Published: (2022-07-01)